Direct Analysis in Real Time-Mass Spectrometry Measurement of Antifungals in Human Serum: A Proof-of-Concept Study

Authors

  • Julie A Ray ARUP Laboratories, Salt Lake City, Utah Author
    • Investigation
    • Methodology
    • Writing – Original Draft Preparation
    • Writing – Review & Editing
  • Stephen D. Merrigan ARUP Laboratories, Salt Lake City, Utah Author
    • Writing – Review & Editing
  • Preejith Vachali Robert J. Tomsich Department of Pathology and Laboratory Medicine, 9500 Euclid Ave, Cleveland, OH 44195 Author
    • Writing – Review & Editing
  • Terry L Bates Quantera Analytical Cornell University Ithaca, New York, NY , USA Author
    • Writing – Review & Editing
    • Investigation
    • Methodology
  • Zahuindanda Aventura Bruker Applied Mass Spectrometry Author
    • Investigation
    • Methodology
    • Writing – Review & Editing
  • Samuel Putnam Bruker Applied Mass Spectrometry Author
    • Investigation
    • Methodology
    • Writing – Review & Editing
  • Gwendolyn McMillin NMS Labs Author
    • Visualization
    • Writing – Review & Editing
  • Mark A Fisher ARUP Laboratories, Salt Lake City, Utah Author
    • Visualization
    • Writing – Review & Editing
  • Kamisha L. Johnson-Davis ARUP Laboratories, Salt Lake City, Utah Author
    • Visualization
    • Writing – Review & Editing

DOI:

https://doi.org/10.21627/x6vfj859

Keywords:

Direct Analysis in Real Time, DART-Mass spectrometry, antifungals, LC-MS, Liquid-Liquid extraction

Abstract

INTRODUCTION: Direct analysis in real time (DART) is a soft ionization technique that uses a heated gas such as helium, argon, or nitrogen to generate a cascade of ionized atmospheric molecules that subsequently ionize analytes in biological samples. OBJECTIVES: In this proof-of-concept study evaluating selected antifungals in human serum, 5-fluorocytosine (5FC), itraconazole (ITR), hydroxyitraconazole (OH-ITR), isavuconazole (ISV), ketoconazole (KETO), fluconazole (FLU), and posaconazole (POSA) were assessed as DART candidates using a Bruker EVOQ® DART-TQ+. METHODS: Human serum samples were extracted using protein precipitation or liquid–liquid extraction. Quantification was performed by DART tandem mass spectrometry (DART-MS/MS) with internal standards. Precision and linearity across individual analytical measurement ranges (AMRs) were evaluated with rapid sample acquisition (0.24 min linear scans), and the results were compared with those obtained using validated LC-MS/MS methods. RESULTS: Linearity and precision were acceptable for all evaluated compounds. Good agreement with LC-MS/MS was observed for 5FC, ITR, OH-ITR, and FLU, with slopes ranging from 0.875 to 1.112 and correlation coefficients (r) ≥ 0.949. POSA extraction by protein precipitation resulted in high bias; however, liquid–liquid extraction or the use of an alternative ion transition reduced bias to <7%. DART replicates demonstrated coefficients of variation <15%. All samples met ion-ratio tolerance criteria of ±50%. CONCLUSION: This proof-of-concept study demonstrates the feasibility of quantitative antifungal measurement in human serum using DART-MS/MS with simple sample preparation. A moderate linear association with bias for POSA was likely attributable to matrix effects. More selective sample preparation may improve DART accuracy. Overall, DART-MS/MS shows promise as a rapid, high-throughput alternative to conventional LC-MS/MS.

Author Biographies

  • Julie A Ray, ARUP Laboratories, Salt Lake City, Utah

    Lead Scientist, Mass Spectrometry

  • Stephen D. Merrigan, ARUP Laboratories, Salt Lake City, Utah

    R&D Scientific Manager • R&D Mass Spectrometry

  • Preejith Vachali, Robert J. Tomsich Department of Pathology and Laboratory Medicine, 9500 Euclid Ave, Cleveland, OH 44195

    Clinical Biochemistry Fellow

    Robert J. Tomsich Department of Pathology and Laboratory Medicine

  • Terry L Bates, Quantera Analytical Cornell University Ithaca, New York, NY , USA

    Founder/CEO

    Quantera Analytical

     

  • Zahuindanda Aventura, Bruker Applied Mass Spectrometry

    Senior Applications

    Development Specialist

  • Samuel Putnam, Bruker Applied Mass Spectrometry

    Applications Scientist at Bruker

  • Gwendolyn McMillin, NMS Labs

    Vice President of Clinical Scientific Engagement

    NMS Labs

  • Mark A Fisher, ARUP Laboratories, Salt Lake City, Utah

    Medical Director

  • Kamisha L. Johnson-Davis, ARUP Laboratories, Salt Lake City, Utah

    Professor (Clinical)

    University of Utah Health 

    Department of Pathology 

Published

2026-07-29

Issue

Section

Research Article

How to Cite

1.
Direct Analysis in Real Time-Mass Spectrometry Measurement of Antifungals in Human Serum: A Proof-of-Concept Study. J Mass Spectrom Adv Clin Lab [Internet]. 2026 Jul. 29 [cited 2026 Aug. 10];39(1). Available from: https://jmsacl.journals.sup.org/index.php/jmsacl/article/view/87